Position in CRDL
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$7,132
-$22,092 QoQ
Shares Held
6,729
-68.9% QoQ
Ownership
0.006%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#42
of 52 holders
Holding Since
Sep 2021
20 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in CRDL Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026ROYAL BANK OF CANADA holds $624,876,780 across 66 Drug Manufacturers - Specialty & Generic names. CRDL ranks #50 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RDY |
Dr Reddys Laboratories Ltd
|
9,213,269 | $133,500,266 | |
| 2 | ZTS |
Zoetis Inc.
|
1,828,326 | $131,383,499 | |
| 3 | NBIX |
Neurocrine Biosciences Inc
|
583,476 | $98,339,041 | |
| 4 | BHC |
Bausch Health Companies Inc.
|
10,832,582 | $53,404,627 | |
| 5 | VTRS |
Viatris Inc
|
3,135,460 | $49,791,098 | |
| 6 | UTHR |
UNITED THERAPEUTICS Corp
|
62,600 | $33,918,552 | |
| 7 | TEVA |
Teva Pharmaceutical Industries Ltd
|
953,413 | $32,301,629 | |
| 8 | HLN |
Haleon plc
|
3,385,489 | $31,586,609 |
All Filings in CRDL
Export CSV
20 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $7,132 | 6,729 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $29,224 | 21,648 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $12,728 | 13,342 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $13,321 | 12,450 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $27,613 | 20,304 | Shares | Defined | 2025-11-21 | |
| 2025-03-31 | $12,429 | 12,814 | Shares | Defined | 2025-11-21 | |
| 2024-12-31 | $31,745 | 24,801 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $47,777 | 24,130 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $54,751 | 27,105 | Shares | Defined | 2024-11-06 | |
| 2024-03-31 | $29,736 | 16,429 | Shares | Defined | 2024-11-05 | |
| 2023-12-31 | $28,751 | 34,107 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $39,781 | 44,449 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $34,460 | 38,721 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $25,628 | 52,626 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $13,337 | 26,151 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $30,321 | 29,439 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $30,774 | 23,314 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $53,877 | 35,214 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $39,208 | 21,194 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $58,908 | 14,195 | Shares | Defined | 2021-11-15 | |
| No filing history on record for this holder in this stock. | ||||||